DNA Synthesizer Market Size, Share, Opportunities, And Trends By Type (Benchtop DNA Synthesizers, Large-scale DNA Synthesizers), By Application (Drug Discovery & Engineering, Clinical Diagnostics), By End-User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories), And By Geography - Forecasts From 2023 To 2028

The DNA synthesizer market is estimated to grow at a CAGR of 7.43% during the forecast period.

Throughout the projection period, it is predicted that the DNA synthesizer market would expand steadily. The tools known as DNA synthesizers are used to decipher a specific DNA molecule from a given sequence of nucleotides. By substituting damaged DNA with repaired DNA, DNA synthesizers assist in the creation of DNA molecules to treat diseases. The players that are active in the global DNA synthesizer market include Gen Script, Synbio Technologies, Ansa Biotechnologies, and Camena Bio. DNA synthesizers are different from cycle times in which they are set to handle batch-wise analysis. This computer-based synthesizer is controlled simply using the website.

DNA synthesizer market growth prospects

Technology advancements, including new genes, enzymes, the newest software, and other elements, are expected to speed up the synthesizing process. The DNA synthesizer industry is expanding as a result of the rising demand for the most cutting-edge technologies, such as Next Gen Sequencing (NGS).  Global demand for DNA synthesizers has been spurred by rising research and investment in synthetic biology. Additionally, the National Human Genome Research Institute (NHGRI), whose funding made DNA sequencing possible, has maintained track of the expenditures involved.

Rising demand for novel synthesis technologies

The main drivers of the worldwide DNA synthesizer market are the rising need for innovative synthesis technologies and technical developments. Furthermore, new opportunities for DNA synthesizer industry participants have been created by advancements in nucleic acid production techniques. For instance, DNA Script's SYNTAX STX-100 system is the first DNA printer that uses enzymatic synthesis to produce bespoke oligos on demand in a benchtop solution. Additionally, these synthesizers include greater speed and flexibility modules that let professionals make unique oligos faster. Similar to this, the Kilobaser RNA and DNA synthesizer was created to give researchers autonomous access to essential life science tools. Even inexperienced workers can successfully finish an RNA or DNA synthesis swiftly due to chip and cartridge technologies.

Increasing demand for benchtop DNA synthesizers

Benchtop DNA synthesizer demand is expected to grow throughout the forecast period due to its significant potential to speed up and improve the efficiency of research in academic and industrial labs. As a result, manufacturers are being compelled by the increase in demand for tabletop solutions to provide dependable benchtop systems. For instance, DNA Script announced the introduction of the SYNTAX system in June 2021. This is the first benchtop nucleic acid printer supported by EDS technology, and it will improve processes in genomics and molecular biology. These synthesizers are expected to accelerate the DNA synthesizer market growth. Additionally, there have been more recent initiatives to commercialize scalable DNA synthesizers and to cut the cost of producing DNA oligonucleotides.

Increasing use in drug discovery and development

Technological developments, increased use of high-throughput technologies, widespread use of DNA synthesizers in drug discovery, and the existence of several DNA synthesizer market players with strong product portfolios are anticipated to drive DNA synthesizer market growth. Another element promoting the development is the increased need from pharmaceutical companies for sophisticated synthesis tools to improve productivity. For instance, Twist Bioscience announced in June 2022 that it will use its DNA synthesis platform to break down barriers to drug discovery. This enabled the firm to increase its capacity for medication development.

Rising demand for diagnostic activities

During the anticipated period, the DNA synthesizer market would rise due to the increasing requirement of diagnosing various diseases. About 30 million Americans are estimated to have undiagnosed or uncommon conditions, making up about 1 in 10 of those who have continuous Type-2 diabetes mellitus. Accurate diagnosis is essential for a better knowledge of the condition and its treatment, as it prevents individuals from passing the issue on to future generations. For instance, NTX-250, an oncology mRNA therapy, was unveiled by Nutcracker Therapeutics, Inc. It could cause an immunological reaction in human HPV and generate anti-tumor responses in mouse cancer models.

Synthetic biology uses DNA synthesizers

The need for therapeutic genome editing and disease diagnostics is increasing, which is driving the DNA synthesizer industry. The use of DNA storage, molecular diagnostics, and biological medicine are all part of synthetic biology, which reportedly raises the need for sophisticated devices to identify DNA strands. Natural medicine is made from living things that can recognize, stop, and cure a wide range of ailments. Additionally, this medication is expensive to buy since it must be prepared with difficult-to-find chemical components.

Growing demand in biotechnology and pharmaceutical companies

For the development of innovative genetic treatments and the process of drug discovery, the majority of pharmaceutical and biotech businesses employ synthetic DNA. As a result of the growing desire for precision medicine and innovative treatment methods, biotechnology and pharmaceutical industries anticipate a major rise in demand for synthesizers in the years to come. Another element driving DNA synthesizer market growth is the emphasis placed on the creation and deployment of fresh platforms that can boost synthesis by top DNA synthesizer industry participants. The business added that the pharma and biotech companies might extend their pipeline by leveraging automation.

The North American DNA synthesizer market is anticipated to grow

During the anticipated period, North America will hold the top spot in the DNA synthesizer market. Autoimmune illnesses are more common than ever in North America, which includes the US, Canada, and Mexico. Significant worldwide income is a result of the North American region having the greatest number of major companies. Around 5-6% of Americans, according to the National Institutes of Health (NIH), are afflicted by autoimmune illnesses. The North Chicago, Illinois-based biotech business AbbVie, which mostly deals in immunology medications, generated $58.05 billion in revenue in 2022. In the next years, there will be a greater need for immunological testing from various DNA synthesizers fueling the DNA synthesizer market growth.

Market Key Developments

• In April 2023, Tekna secured three orders for plasma systems totaling $2.6 million and focused on developing additional appliances. These customers are from Latin America, Asia, and Europe.
• In February 2023, to cut costs and save time, AstraZeneca automated its DNA production capabilities.
• In May 2022, thermally regulated DNA synthesis received a patent, according to EVONETIX LTD. Nucleic acid synthesis may be carried out using the patented technology on a benchtop synthesizer platform.
• In March 2022, to launch a major client program for completely enzymatic DNA synthesis, Molecular Assemblies, Inc. secured USD 25.8 million in series B investment.

DNA Synthesizer Market Scope:

 

Report Metric	Details
Growth Rate	CAGR of 7.43% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Type, Application, End-User, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Kilobaser, DNA Script, Evonetix, Twist Bioscience, Labiotech, Genome Web, CSBio, Telesis Bio, Eurofins Genomics LLC, Honya Biotech
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Type
  • Benchtop DNA Synthesizers
  • Large-scale DNA Synthesizers
• By Application
  • Drug Discovery & Engineering
  • Clinical Diagnostics
• By End-User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Clinical Laboratories
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. DNA SYNTHESIZER MARKET, BY TYPE

5.1. Introduction

5.2. Benchtop DNA Synthesizers

5.3. Large-scale DNA Synthesizers

6. DNA SYNTHESIZER MARKET, BY APPLICATION

6.1. Introduction

6.2. Drug Discovery & Engineering

6.3. Clinical Diagnostics

7. DNA SYNTHESIZER MARKET, BY END-USER

7.1. Introduction

7.2. Academic & Research Institutes

7.3. Pharmaceutical & Biotechnology Companies

7.4. Clinical Laboratories

8. DNA SYNTHESIZER MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Kilobaser

10.2. DNA Script

10.3. Evonetix

10.4. Twist Bioscience

10.5. Labiotech

10.6. Genome Web

10.7. CSBio

10.8. Telesis Bio

10.9. Eurofins Genomics LLC

10.10. Honya Biotech

Kilobaser

DNA Script

Evonetix

Twist Bioscience

Labiotech

Genome Web

CSBio

Telesis Bio

Eurofins Genomics LLC

Honya Biotech